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Background: Diabetes self-management often involves the interpretation and application of oral, written, or
quantitative information. Numerous diabetes patients in China have limited health literacy, which likely leads to
poorer clinical outcomes. This study is designed to examine the efficacy and cost-effectiveness of addressing health
literacy to improve self-management skills and glycemic control in Chinese diabetes patients.
Methods/design: This is a cluster randomized controlled trial (RCT) conducted in 20 community healthcare sites in
Shanghai, China. Overall, 800 diabetes patients will be randomized into intervention and control arms and will have
a baseline hemoglobin A1c (HbA1c) assay and undergo a baseline survey which includes measures of health
literacy and diabetes numeracy using revised Chinese versions of the Health Literacy Management Scale and
Diabetes Numeracy Test Scale. During the 1-year period of intervention, while the control group will receive usual
care, the intervention group will be supplemented with a comprehensive health literacy strategy which includes i)
training healthcare providers in effective health communication skills that address issues related to low literacy, and
ii) use of an interactive Diabetes Education Toolkit to improve patient understanding and behaviors. Assessments
will be conducted at both patient and healthcare provider levels, and will take place upon admission and after 3, 6,
12, and 24 months of intervention. The primary outcome will be the improvement in HbA1c between Intervention
group and Control group patients. Secondary outcomes at the patient level will include improvement in i) clinical
outcomes (blood pressure, fasting lipids, body mass index, weight, smoking status), ii) patient reported
self-management behaviors, and iii) patient-reported self-efficacy. Outcomes at the provider level will include:
i) provider satisfaction and ii) intensity and type of care provided. The effects of the intervention will be examined
in multivariable general linear models. Both cost-effectiveness and cost-utility analyses will be performed.
Discussion: The main strengths of this study are its large sample size and RCT design, involvement of both patients
and healthcare providers, and the long term follow-up (24-months). This project will help to demonstrate the value
of addressing health literacy and health communication to improve self-management and clinical outcomes among
Chinese diabetes patients.
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The rising worldwide prevalence of type 2 diabetes mel-
litus (T2DM) has been very well documented. In China,
the prevalence of T2DM tripled between 1980 (about
1.0%) and 1996 (3.2%) [1,2], and reached 9.7% in 2008
among adults at 20 years old or above [3]. It is estimated
that over 92 million adults in China have T2DM; this
represents approximately half of the world’s diabetic
population and places China at the “global epicenter of
the diabetes epidemic” [4].
T2DM is a chronic condition that requires patients to
follow specific recommendations and prescriptions for the
rest of their lives. Due to the lifelong health care it entails
and the huge number of diabetic patients, diabetes self-
management has become a major component of compre-
hensive diabetes care around the world. However, less than
50% of recommended guidelines for diabetes management
are currently achieved in the United States [5,6]. In China,
where the diabetes self-management strategy has been ap-
plied for a couple of years and diabetes education has been
suggested to achieve better glycemic control [7,8], only
one-fifth of diabetic patients were reported to achieve
hemoglobin A1c (HbA1c) levels of less than 6.5% [9]. One
possible reason for this modest effect may be that previous
diabetes management did not specifically address issues of
health literacy or numeracy. The self-management of dia-
betes often involves interpretation of quantitative informa-
tion and the performance of calculations. However, a large
number of patients have poor health literacy and numer-
acy, which lead to incomprehension of basic health infor-
mation, lower likelihood of receiving preventive care,
limited ability to take medications appropriately, higher
hospitability, poorer glycemic control status, and worse
clinical outcomes.
Literacy has been defined as “an individual’s ability to
read, write, speak, and compute and solve problems at
levels of proficiency necessary to function on the job and
in society, to achieve one’s goals, and develop one’s know-
ledge and potential” [10]. Patients with low literacy may
have trouble in reading prescriptions, following medical
instructions, and interacting with the health care system.
Patients with low literacy usually have lower disease-
specific knowledge, report lower quality of life, and have
poorer health related outcomes – even after adjusting
for potential confounders such as educational level, in-
surance, and other factors [10-12]. Numeracy, as an im-
portant component of literacy, can be defined as the
ability to understand and use numbers in daily life [13].
Numeracy is particularly important to patients with dia-
betes because diabetes requires self-management skills
that rely on mathematics such as counting carbohy-
drates, interpreting glucose monitoring, applying a slid-
ing scale for insulin, and calculating insulin doses based
on carbohydrate intake. These skills require not onlybasic math skills, but also the ability to apply those math
skills in the context of diabetes care (that is, diabetes-
related numeracy).
Low literacy is common among patients with diabetes,
and appears closely associated with less knowledge of
diabetes self-management and worse clinical outcomes
[11,12,14,15]. Williams et al. [15] found that 55% of dia-
betes patients in the United States had inadequate literacy.
It was reported that, of patients with inadequate literacy,
50% did not know the symptoms of hypoglycemia, 62%
did not know how to treat hypoglycemia, and 42% did not
know the normal blood glucose range despite the fact that
73% of the patients had attended previous diabetes educa-
tion. Among over 400 patients with diabetes, Schillinger
et al. [14] observed an independent association of poor lit-
eracy with worse glycemic control and higher rates of ret-
inopathy. Most of the studies, to date, on the role of
literacy in health care have focused specifically on verbal
literacy with little examination of quantitative skills. While
there is a strong correlation between verbal literacy and
quantitative skills, there are many patients who have ad-
equate verbal literacy but are still unable to use math skills
appropriately or are anxious/intimidated about math [16].
Recent studies have demonstrated that providing low lit-
eracy materials or low literacy forms of communication
can improve patient comprehension for patients with both
low and high literacy [17,18]. A randomized controlled
trial (RCT) of a comprehensive disease management inter-
vention demonstrated that literacy was a significant factor
in predicting patients’ improvement in HbA1c from the
intervention, and suggested that addressing literacy could
improve patient outcomes [11]. Two coordinated RCTs
performed at two academic medical centers of the United
States from 2006 to 2008 rigorously examined the role of
addressing both literacy and numeracy, and found that the
literacy- and numeracy-sensitive diabetes care can lead to
significant improvements in glycemic control, self-efficacy,
and other outcomes [19].
So far, very few studies have been specifically designed to
address the association of literacy and numeracy with dia-
betes self-management skills in China. A survey conducted
in older diabetes patients in Beijing showed that diabetes
knowledge was very limited in this population [20]. In a
study conducted in Hong Kong, a negative correlation was
observed for health literacy with diabetic control status
among diabetes patients [21]. Innovative approaches to
diabetes management and education are urgently needed
in this population, who has a high prevalence of diabetic
complications. Addressing literacy and numeracy through
improved healthcare provider communication skills and
improved educational materials is a potentially successful
strategy. It is an innovative approach to optimize patient
understanding, promote shared decision-making, and en-
hance patient self-efficacy and self-management behaviors.
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health literacy strategy and evaluate its utility among
Chinese diabetes patients. We will report the outcomes of
the economic evaluation in a separate article.
The primary outcome of the current study is improve-
ment in HbA1c. We hypothesize that participants random-
ized to the intervention arm will have a significantly lower
HbA1c level when compared to the control group parti-
cipants. Secondary outcomes are improvements in blood
pressure, lipids, self-management behavior, self-efficacy,
and other patient outcomes important to improving dia-
betes care, as well as improved health communication
skills and increased satisfaction in health care providers.
We hypothesize that patients in the intervention condition
will report beneficial changes while the health care pro-
viders will be more satisfied with treatment than those in
the control condition. A further aim of this study is to
evaluate the cost-effectiveness and cost-utility of the inter-
vention. We hypothesize that the intervention will be per-




This is a cluster RCT with blinded data analysis (Figure 1).
Prior to the trial, we conducted a validation study in 408
diabetes patients in Pudong New area of Shanghai to as-
sess the validity of diabetes-related numeracy test scale in
Chinese patients (C-DNT-5). We also performed a pilot
study in 80 diabetes patients from eight Community
Healthcare Centers in Minhang and Changning district of
Shanghai, China, to examine the feasibility and acceptabil-
ity of intervention and research procedures. We obtained
informed consent from each study participant. The results
of the two studies have been used to inform the develop-
ment of the forthcoming trial.
Setting
A total of 800 diabetes patients will be recruited from
eight Community Healthcare Centers in Minhang and
Changning district of Shanghai, China. Five clinic sites
will be selected from each Center. All clinic sites meet
the following criteria: i) at least 20 patients can be re-
cruited per site; ii) at least 2 to 4 physician(s), nurse
practitioner(s), or diabetes educator(s) per Center can
participate in the intervention; iii) the site agrees to par-
ticipate for a minimum of 2 years; and iv) the site agrees
to be randomized to either arm of the study.
Inclusion and exclusion criteria for participants
Inclusion criteria at the patient level will include: i) pa-
tient has a clinical diagnosis of T2DM; ii) age 18 to
85 years; iii) most recent HbA1c ≥7.5%; iv) patient
provides signed informed consent form; and v) patientagrees to participate in the study for the full 2-year dur-
ation. Exclusion criteria at the patient level will include:
i) poor visual acuity (vision worse than 20/50 using
Rosenbaum Pocket Screener); ii) significant dementia
or psychosis (by health provider report or chart re-
view); and iii) terminal illness with anticipated life ex-
pectancy <2 years.
Analytical power
According to our previous survey, the mean (SD) of
HbA1c among 934 randomly selected diabetes patients
was 8.0% (1.4%) [22]. We anticipate a 0.8% improvement in
HbA1c level from baseline to 12 months, with a conserva-
tive estimate of the SD at 2.0. We performed a simulation
study generating follow-up HbA1c using the following for-
mula: Follow-up HbA1c = Baseline HbA1c + β* Group +
Site Effect + Provider Effect + δ. Group is a binary variable
indicating 0 for control and 1 for intervention group. For
800 patients recruited, we anticipate n = 560 for the final
analysis after subtracting 30% loss to follow-up. We will
perform multiple imputation for the missing data where all
800 subjects will be used in the analysis; however, our sam-
ple size is estimated with the analysis excluding missing ob-
servations to provide the most conservative estimate.
Assuming 0.8% reduction in HbA1c with the intervention
compared with the control group at 12-month follow-up,
the proposed analysis will yield analytical power of 100.0%
with two-sided 5% significance level.
A simpler sample size calculation than our simulation
model would not account for the double clustering de-
sign. Using a popularly used formula estimating sample
size with single clustering for 40 sites, power is also
100.0% with two-sided 5% significance level to detect the
difference of 0.8% in HbA1c.
Randomization procedure
Randomization will occur at the level of the Community
Healthcare Centers. Four Centers (20 clinic sites) will be
randomized to receive the intervention and four centers
(20 clinic sites) will be randomized to the control condi-
tion. To minimize potential imbalance in randomization,
we will employ a multivariable score based pair-wise
matching method [23] to achieve the optimal balance by
location, size, population covered, HbA1c level, and other
characteristics of recruited patients including age, gender,
insurance status, insulin status, and body weight. We will
first weigh covariates according to relevance of potential
bias introduced, and then compute a multivariable score
using an established algorithm after data are standardized
and appropriately weighted. We will then identify four
matched pairs, with each pair consisting of two facilities
with closest multivariable scores. Randomization will be
performed within each pair, with one Center randomized
to receive the intervention, and the other to the control
Follow-up survey and assay at 3, 6, 12 and 24 months visit
Figure 1 Flowchart of the study.
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sible pair-wise combinations for randomization. We will
then assess balance for each covariate as a proportion of
imbalance detected over all combinations. When balance
is not ideal, the process will be repeated after adjusting the
weighting system. After an appropriate weighting scheme
is determined, the centers will be paired and a final
randomization will be performed. This procedure will en-
sure more comparable patient populations with respect to
clinic characteristics. Randomization at the Center levelwill help avoid contamination issues at the healthcare pro-
vider level.
Usual care
In the control arm, usual diabetes care will continue
according to current national guidelines: conventional
clinical consultations, treatment provision according to
existing knowledge and at the individual clinician’s discre-
tion, no training in communication skills, and no literacy-/
numeracy-sensitive Diabetes Education Toolkit materials.
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educate healthcare providers about diabetes care based
on the latest diabetes management recommendations
and educational materials from the Chinese Guideline
for Diabetes Care and Education, which will help to con-
trol for Hawthorne effects that might result in improved
care.
Intervention
The intervention will include two main components: i)
the Partnership to Improve Diabetes Education Toolkit
(PRIDE), a set of plain-language tools to aid provider-
patient communication about diabetes management, and
ii) a Clear Health Communication Curriculum, a struc-
tured training program for healthcare providers to im-
prove diabetes-related counseling communication skills,
with specific attention to issues of literacy and numeracy.
Diabetes education toolkit (PRIDE)
The PRIDE toolkit will consist of a host of educational
materials that have been designed specifically to improve
patient understanding and self-management behaviors in
patients with lower literacy or numeracy skills. The
PRIDE toolkit will be based on the Diabetes Literacy and
Numeracy Education Toolkit developed and validated
previously [24].
The materials in the PRIDE toolkit are designed spe-
cifically to help educate diabetes patients about self-
management skills, with 24 educational modules covering
all components of diabetes self-management including
diet, exercise, foot care, glucose monitoring, and medica-
tion management, and enhanced diabetes log sheets that
can be shared with patients to help improve their self-
management. The modules are written at a low literacy
level with many pictures, white space, and other accom-
modations for low literacy patients. Sample numeracy-
oriented accommodations include color coding to help
with number hierarchy, the use of insulin pens or syringes
with colored marks to aid patients with difficulty measur-
ing insulin, the use of tables and sentences to simplify
medication instructions, and simplifying instructions by
providing more basic alternatives that do not need as
many math skills (e.g., a “plate method” or color coded
scoop method instead of carbohydrate counting). For tasks
that require math skills, worksheets are provided for pa-
tients to practice skills to help gain proficiency.
The toolkit is designed to help accommodate patients of
all literacy levels, particularly those with poor literacy or
numeracy skills. The PRIDE toolkit also acts as a disease
management intervention at the provider and system level
by i) acting as a “reminder” system to providers about cer-
tain treatment goals, ii) providing a structured approach
to addressing self-management goals, including “care algo-
rithms” that promote more systematic approaches to care,and iii) materials addressing important socioeconomic and
community level barriers that can impede diabetes care.
Providers in the intervention Centers will be trained in
the proper use of the PRIDE toolkit materials and will be
expected to use the materials during regular patient-
related visits. At each visit, providers will be asked to cover
at least two components from the toolkit materials, and to
perform and document at least one goal-setting task with
the patient. They will share components of the toolkit dir-
ectly with the patients for the patients to use and take
home with them. Providers will be expected to spend ap-
proximately 5 to 7 minutes per visit using the toolkit mate-
rials with the patients. We anticipate that visits will occur
at least every 3 months, in accordance with American
Diabetes Association guidelines for diabetes follow-up, or
more frequent, as needed. Paper printouts of toolkit mate-
rials will be made available in central locations in the inter-
vention Centers for easy access.
Clear health communication curriculum for health care providers
Healthcare providers in the intervention arm will be
trained in improved health communication skills with a
specific emphasis on improving communication to aid
patients with poor literacy or numeracy skills. All inter-
vention clinic health care providers (physicians, nurse
practitioners, registered nurses, dieticians, and health
educators) will gather to obtain an approximately 5 to
6 hour training before the initiation of the intervention.
The on-site training of the healthcare providers is essen-
tial to promote intervention fidelity and allow rigorous
evaluation of the impact of the intervention. To promote
provider participation, we will provide certificates with
scores of Continuing Medical Education to all providers
that participate in the training; we will also provide other
nominal incentives for participation (free educational
materials, food, pens, etc.).
During the training session, the healthcare providers will
receive informational and hands-on training in the follow-
ing areas: i) diabetes management, ii) introduction to the
diabetes education toolkit, iii) clear health communication
skills, and iv) application of the diabetes education toolkit
using principles of clear health communication.
All intervention health care providers will undergo a
post-training certification process to ensure that they
have learned the materials. Healthcare providers will
meet certification if they accomplish >90% of items
listed on a Health Care Provider Certification Checklist
at the end of the training day. Providers who fail this
certification process will need to participate in additional
1:1 training with the research team until they meet ad-
equate certification criteria. If a provider cannot meet
certification requirements, then the participating Center
will need to identify additional health care providers to
participate in the study.
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Baseline survey
We will collect baseline characteristics related to the pa-
tients and the healthcare providers, which include the
following variables:
Patients: Age at study entry, gender, date of birth, number
of years living in Shanghai, household composition
(number of children, marital status, etc.), Mandarin
proficiency, health insurance status, employment, income
level, years of education, lifestyle (smoking status, dietary
habits, and physical activity), literacy level (as measured
by the validated Chinese versions of Health Literacy
Management Scale) [25], diabetes-related numeracy
(as measured by the C-DNT-5), and measures related
to clinical history, including years of diabetes, current
diabetes medications, history of diabetes education, and
glucose monitoring frequency.
Healthcare Providers: age, gender, years of education,
type of provider (physician, nurse, dietician), Certified
Diabetes Educator Status (Yes or No), and satisfaction
for health care.
Collection of measures
HbA1c and lipids tests will be performed throughout the
study using Point-of-Care Equipment available in each
Community Health Center (high-performance liquid chro-
matography for HbA1c, and Automatic Analyzer for
Lipids). Self-management activities will be assessed using
the previously validated Chinese version of Summary of
Diabetes Self-Care Activities [26]. Self-efficacy will be












Use of intervention (Toolkit) or control (Chinese Guideline for Diabetes Care
Education) materials*
Certification of training
*Intervention providers will document after each visit what components of the Diab
Chinese Guideline for Diabetes Care and Education materials they used.The majority of measures will be collected at baseline
and 3, 6, 12, and 24 months. The schedule for data col-
lection is summarized in Table 1.
Related cost
Fixed and variable costs of the intervention program will
be estimated, as well as the short-term and long-term
cost-effectiveness of the program. The intervention costs
will be subdivided into four categories of costs:
i. Implementation fixed costs will include all labor,
supply, and space costs of initiating and running the
program that are independent of the number of
participants in the program. These costs include the
cost for program site personnel to attend training
sessions before initiation of the program as well as
during the program, and the cost of setting up a
system to run the program from the clinic site.
ii. Implementation variable costs will include all labor,
supply, and space costs of running the program that
are dependent on the number of program
participants. These costs include printing costs for
educational materials, labor costs for educating and
monitoring the patients, and space costs for storing
materials and meeting with patients. All program-
related activities that occur within a 2-week time
window will be timed using stop watches. These
activities will include preparation for the patients’
clinic visits (including gathering educational materials),
the clinical encounter, follow-up telephone calls with
the patients, and documentation of the visit. These
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etes Education Toolkit they used. Control providers will document what
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estimated according to the individual’s salary level.
Supply and space use for each program activity will
also be determined. Costs will be applied to the
supplies used based on wholesale acquisition costs.
Costs will be applied to clinic visit and storage space
used based on standard space overhead rates applied
at the program sites. Variation in the fixed and variable
implementation costs across the different program
sites will be reported.
iii. Disease-related costs will be derived from health
service use data collected during the trial. This will
include outpatient drugs prescribed including the dose
and duration of therapy, physician visits, laboratory
tests, emergency room visits, and hospitalizations.
Standard charge will be used to estimate the unit costs
for each type of health service, including the medical
chart review and extracting, medical insurance system
query, and the Physician’s Fee Reference for any
healthcare provider costs.
iv. Patient-related costs, including travel time and costs,
total time in the clinic (including time to register, to
wait to be seen, to meet with the providers, and to
check-out of the clinic), and other incidental costs
for each physician and emergency room visit, will be
measured using a patient survey administered to all
patients visiting the physician or emergency room
during the 2-week time window in which the study
is being completed. In sensitivity analyses, disability-
related costs related to lost work will also be
included.
Program development- and research-related costs will
not be estimated since they are one-time only costs and
would not be incurred when using the program mate-
rials in other populations after the end of the study.
Quality control
A local project office will be set up in each Community
Healthcare Center to monitor patient recruitment, con-
sent, and collection of measures. One project officer at
each Center will be trained in the recruitment of all pa-
tients, including those with lower literacy skills. This
process will be rigorously overseen by the Principal Inves-
tigator and research team. In addition, the Study Project
Coordinator at Fudan University will provide oversight
over the project officers. All data will be key-entered in
Fudan University.
Statistical analyses
Comparison of participants by intervention and literacy
status will be conducted using χ2 tests (for categorical
variables) and t-tests or Wilcoxon rank-sum tests (for
continuous variables). Analysis of covariance will beused to evaluate the improvement in HbA1c levels after
adjusting for baseline values. Multivariable general linear
models will be used to additionally adjust for other base-
line covariates including age, sex, and diagnosis date.
Two types of cost-effectiveness ratio (CEA) will be per-
formed: i) a short-term 1-year CEA using a surrogate
clinical endpoint, HbA1c, and ii) a long-term lifetime
CEA with the outcome measure of quality-adjusted life-
years gained. The short-term CEA will use the results of
the 1-year cost and clinical analyses to compute the
cost-effectiveness ratio, incremental cost per additional
person with a reduction of >1% in HbA1c level. The
95% confidence limits for the cost and clinical outcomes
measures will be used as input parameter value ranges
tested in one-way sensitivity analyses. The long-term
CEA will be performed using the Center for Disease
Control Diabetes Cost-Effectiveness Group Model that
evaluates the cost-effectiveness of intensive glycemic
control, blood pressure control, and cholesterol control
in people with diabetes [28]. All analyses will be per-
formed using SAS version 9.13.
Approval was obtained from the Medical Ethics
Committee of School of Public Health, Fudan University
(IRB00002408 & FWA00002399) (registration number:
2013-06-0451). The involved local medical ethics commit-
tees in the Center for Disease Control and Prevention of
Changning District and the Center for Disease Control
and Prevention of Minhang District agreed with this
approval.
Discussion
This article describes the study protocol of a cluster RCT
examining the efficacy and cost-effectiveness of addressing
health literacy and numeracy to improve self-management
skills and glycemic control in Chinese diabetes patients.
The results of the RCT will rigorously demonstrate that
addressing poor health literacy and numeracy in prac-
tical, “real world” settings can significantly improve self-
management skills and clinical outcomes for patients with
T2DM. The research will also demonstrate that this type
of intervention can be performed on a large scale in a way
that is practical, cost-effective, and sustainable.
We hypothesize that participants randomized to the
intervention arm will have significant improvements in
HbA1c, blood pressure, lipids, self-management behavior,
self-efficacy, and other patient outcomes important to im-
proving diabetes care when compared to the control group
participants. We also hypothesize that i) patient health lit-
eracy or numeracy will be a significant effect modifier on
the study impact –among patients with lower literacy or
numeracy skills, those receiving the intervention will have
more significant improvement in HbA1c level and other
outcomes; ii) health care providers in the intervention
group will report improved health communication skills
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viders in the control group; iii) the intervention will be of
modest program costs and will be cost-effective in the long-
term by leading to improved patient clinical outcomes,
decreased complications, and decreased use of high-cost
services such as emergency room visits and hospitalizations.
To date, very few studies have been specifically de-
signed to address the association of literacy and numer-
acy with diabetes self-management skills in Chinese
diabetes patients. If the study hypotheses are confirmed,
the toolkit and the healthcare provider training curricu-
lum and material could be more widely distributed and
applied in diabetes health care, reducing incidence of
diabetic complications and premature mortality, and
limiting the costs due to diabetic complications.
The strengths of this study include data are collection
in a naturalistic setting (the age of patients range from
18 to over 80 years, involvement of both patients and
healthcare providers) and the examination of hypotheses
in a RCT design. A further strength is the size of the
study, in which healthcare providers and diabetes pa-
tients from urban and rural communities are included.
Moreover, 24-month follow-up of participants will pro-
vide an opportunity to evaluate the long-term effect of
the intervention.
A possible limitation of the study is the short 1-year
intervention, which may not be long enough to observe
the effect of the intervention on occurrence of diabetes
complications. In this study, the main outcome is the re-
duction in HbA1c level, which is a surrogate marker for
long-term outcomes. Studies such as the DCCT and the
UKPDS demonstrate that reducing HbA1c by ~0.7% can
reduce micro-vascular complications by as much as 40
to 60%. Lowering HbA1c in T2DM also can decrease
the absolute risk of developing coronary heart disease by
5 to 17% and all-cause mortality by 6 to 15% [29]. We
can assume that if 1-year intervention can decrease
HbA1c level significantly, it will improve long-term out-
comes of diabetes patients. We also include blood pres-
sure and lipid control as clinical outcomes. Second, the
1-year intervention may lead to a high drop-out rate. To
prevent drop-out, local research assistants/nurses will
help patients to complete the questionnaires and will
make appointments for follow-up assessment. Long-term
incentives will also be applied for both the healthcare pro-
viders and the patients. Third, although all Community
Healthcare Centers in Shanghai provide diabetes care
services according to the Guideline of Chinese Diabetes
Prevention and Control, the usual care in the Centers of
Minhang district is somewhat different from that in
Changning district. In order to overcome this limitation,
we will ensure the matched pair of Centers from a same
district. Moreover, the patients will be from the Minhang
district and the Changning district, two of a total of 13districts in Shanghai, China. This may arouse concerns
on the representation of the sample patients and ex-
trapolation of our results to other patients. From a
generalizability perspective, this study will recruit a diverse
population across urban and rural Shanghai, and may be
generalizable to other areas in China. Finally, given that
Shanghai is one of the most economically developed large
cities in China, whose residents have a relatively higher
educational level, the results derived from our population
may underestimate the effect of addressing health literacy
and numeracy to improve self-management skills and gly-
cemic control in Chinese diabetes patients. Nevertheless,
it is plausible that the interventions, if effective in our
population, would work in other populations.
Trial status
Patient recruitment is ongoing.
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